Detail akcie Brooks Aut online

Business Summary: Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company’s segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
Financial Summary: BRIEF: For the three months ended 31 December 2023, Azenta Inc revenues decreased 13% to $154.3M. Net loss increased 40% to $15.7M. Revenues reflect B Medical Systems segment decrease of 70% to $12.6M, Rest of Europe segment decrease of 37% to $24.8M, Africa segment decrease of 56% to $7.5M, Asia/Pacific segment decrease of 23% to $10.8M. Higher net loss reflects B Medical Systems segment loss totaling $4.4M vs. income of $6.3M.